Bibliography
- Breaker RR, Joyce GF. A DNA enzyme that cleaves RNA. Chem Biol 1994;1(4):223-9
- Santoro SW, Joyce GF. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA 1997;94(9):4262-6
- Lu ZX, Ye M, Yan GR, et al. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis. Cancer Gene Ther 2005;12(7):647-54
- Dass CR, Saravolac EG, Li Y, et al. Cellular uptake, distribution and stability of 10-23 deoxyribozymes. Antisense Nucleic Acid Drug Dev 2002;12(5):289-99
- Cairns MJ, Hopkins TM, Witherington C, et al. Target site selection for an RNA-cleaving catalytic DNA. Nat Biotech 1999;17(5):480-6
- Wu Y, Yu L, McMahon R, et al. Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes). Hum Gene Ther 1999;10(17):2847-57
- de Bock CE, Lin Z, Itoh T, et al. Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells. FEBS J 2005;272(14):3572-82
- Fahmy RG, Dass CR, Sun LQ, et al. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularisation and tumour growth. Nat Med 2003;9(8):1026-32
- Mitchell A, Dass CR, Sun LQ, et al. Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor Egr-1. Nucleic Acids Res 2004;32(10):3065-9
- Khachigian LM, Fahmy RG, Zhang G, et al. c-Jun regulates vascular smooth muscle cell growth and neointima formation after arterial injury. Inhibition by a novel DNA enzyme targeting c-Jun. J Biol Chem 2002;277(25):22985-91
- Cieslak M, Niewiarowska J, Nawrot M, et al. DNAzymes to beta 1 and beta 3 mRNA downregulate expression of the targeted integrins and inhibit endothelial cell capillary tube formation in fibrin and matrigel. J Biol Chem 2002;277(9):6779-87
- Wahlestedt C, Salmi P, Good L, et al. Potent and non-toxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci USA 2000;97(10):5633-8
- Fluiter K, ten Asbroek AL, de Wissel MB, et al. In vivo tumour growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides. Nucleic Acids Res 2003;31(3):953-62
- Rockwell P, O'Connor WJ, King K, et al. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci USA 1997;94(12):6523-8
- Fahmy RG, Khachigian LM. Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth. Nucleic Acids Res 2004;32(7):2281-5
- Schubert S, Gul DS, Grunert HP, et al. RNA cleaving ‘10-23’ DNAzymes with enhanced stability and activity. Nucleic Acids Res 2003;31(20):5982-92
- Braasch DA, Corey DR. Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem Biol 2001;8(1):1-7
- Kumar R, Singh SK, Koshkin AA, et al. The first analogues of LNA (locked nucleic acids): phsophorothioate-LNA and 2'-thio-LNA. Bioorg Med Chem Lett 1998;8(16):2219-22
- Abdelgany A, Wood M, Beeson D. Hairpin DNAzymes: a new tool for efficient cellular gene silencing. J Gene Med 2007;9(8):727-38
- Beale G, Hollins AJ, Benboubetra M, et al. Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridisation-accessible region using the same delivery system. J Drug Target 2003;11:449-56
- Kabuli M, Yin JA, Tobal K. Targeting PML/RAR alpha transcript with DNAzymes results in reduction of proliferation and induction of apoptosis in APL cells. Hematol J 2004;5:426-33
- Liang Z, Wei S, Guan J, et al. DNAzyme-mediated cleavage of survivin mRNA and inhibition of the growth of PANC-1 cells. J Gastroenterol Hepatol 2005;20:1595-602
- Dass CR, Khachigian LM, Choong PFM. c-Jun is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasising model. Mol Cancer Res 2008;6(8):1289-92
- Zhang G, Dass CR, Sun LQ, et al. Effect of deoxyribozymes targeting c-Jun on solid tumour growth and angiogenesis in rodents. J Natl Cancer Inst 2004;96:683-96
- Zhang G, Luo X, Sumithran E, et al. Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression. Oncogene 2006;25:7260-6
- Dass CR, Freidhuber AM, Khachigian LM, et al. Downregulation of c-Jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model. Cancer Biol Ther 2008;7(7):1033-6
- Santiago FS, Atkins DG, Khachigian LM. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent. Am J Pathol 1999;155:897-905
- Santiago FS, Lowe HC, Day FL, et al. Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2. Am J Pathol 1999;154:937-44
- Santiago FS, Lowe HC, Kavurma MM, et al. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med 1999;5:1264-9
- Bhindi R, Khachigian LM, Lowe HC. DNAzymes targeting the transcription factor Egr-1 reduce myocardial infarct size following ischemia-reperfusion in rats. J Thromb Haemost 2006;4:1479-83
- Iversen PO, Nicolaysen G, Sioud M. DNA enzyme targeting TNF-alpha mRNA improves hemodynamic performance in rats with postinfarction heart failure. Am J Physiol Heart Circ Physiol 2001;281:H2211-7
- Xiang G, Schuster MD, Seki T, et al. Downregulated expression of plasminogen activator inhibitor-1 augments myocardial neovascularisation and reduces cardiomyocyte apoptosis after acute myocardial infarction. J Am Coll Cardiol 2005;46:536-41
- Xiang G, Seki T, Schuster MD, et al. Catalytic degradation of vitamin D up-regulated protein-1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodelling after myocardial ischemia. J Biol Chem 2005;280:39394-402
- Khan A, Benboubetra M, Sayyed PZ, et al. Sustained polymeric delivery of gene solcening antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies. J Drug Target 2004;12(6):393-404
- Pun SH, Tack F, Bellocq NC, et al. Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumour tissue by transferring-modified, cyclodextrin-based particles. Cancer Biol Ther 2004;3(7):641-50
- Bellocq NC, Pun SH, Jensen GS, et al. Transferrin-containing, cyclodextrin polymer-based particles for tumour-targeted gene delivery. Bioconjug Chem 2003;14(6):1122-32
- Tack F, Bakker A, Maes S, et al. Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes). J Drug Target 2006;14(2):69-86
- Tan Y, Liu F, Li Z, et al. Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mol Ther 2001;3(5 Pt 1):673-82
- Tack F, Noppe M, Van Dijck A, et al. Delivery of a DNAzyme targeting c-myc to HT29 colon carcinoma cells using a gold nanoparticulate approach. Pharmazie 2008;63(3):221-5
- Dass CR, Friedhuber AM, Khachigian LM, et al. Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity. J Microencapsul 2008;25(6):421-5
- Franchi A, Calzolari A, Zampi G. Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumours of the skeleton. Virchows Arch 1998;432(6):515-9
- Papachristou DJ, Batistatou A, Sykiotis GP, et al. Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 2003;32(4):364-71
- Fahmy RG, Waldman A, Zhang G, et al. Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun. Nat Biotechnol 2006;24(7):856-63
- Zimmermann TS, Lee AC, Akinc A, et al. RNAi-mediated gene silencing in non-human primates. Nature 2006;441(7089):111-4